News Cyteir Therapeutics Announces New Data Demonstrating Lead Compound CYT-0851 is Active Against Lymphomas and Solid Tumors; Synergistic with PARP Inhibitors Mar 31, 2019 Posted by Cyteir Therapeutics
News 5TH Annual Science of Stability Conference Announces Location and Themes Mar 29, 2019 Posted by FreeThink Technologies, Inc.